Live Breaking News & Updates on Adhera Therapeutics

Stay updated with breaking news from Adhera therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option

Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , New York , United States , Bukwang Pharmaceuticals Co Ltd , Biodexa Pharmaceuticals , Melior Pharmaceuticalsi Inc , Exchange Commission , Exchange Agreement , Adhera Therapeutics Inc , Ladenburg Thalmann Co , Pfizer Inc , Prospectus Department , Edison Group , Underwritten Public Offering , Including Full Exercise Of Overallotment , Typei Diabetes , Adhera Therapeutics , Depositary Share , Seriese Warrants , Classb Unit , Each Pre Funded Warrant , Pre Funded Warrants , License Agreement , Secured Noteholders , Depositary Shares , United States Securities ,

Short Interest in Adhera Therapeutics, Inc. (OTCMKTS:ATRX) Expands By 81.5%

Adhera Therapeutics, Inc. (OTCMKTS:ATRX – Get Free Report) was the recipient of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 11,800 shares, an increase of 81.5% from the November 15th total of 6,500 shares. Based on an average trading volume of 1,570,700 shares, […] ....

Adhera Therapeutics Inc , Marina Biotech Inc , Adhera Therapeutics , Get Free Report , Marina Biotech , Adhera Therapeutics Daily , Otcmkts Atrx ,

StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers

StockWatch: CAR-T Shares Mostly Flat as FDA Probes Risk of New Cancers
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Canaccord Genuity , John Newman , Redhill Biopharma , Jackk Allen , Alex Philippidis , Brianp Skorney , Bristol Myers Squibb , Melior Pharmaceuticals , Gilead Sciences , Biodexa Pharmaceuticals , Kite Pharma , Events Reporting System , Autolus Therapeutics , Janssen Biotech , Legend Biotech , Cabaletta Bio , Altamira Medica , Adhera Therapeutics , Good Clinical , Hill Biopharma , Generating Antibiotic Incentives Now , Act Qualified Infectious Disease Product , Aphthous Ulcers ,

Biodexa Pharmaceuticals (BDRX) to Acquire Exclusive Worldwide License to Tolimidone

Biodexa Pharmaceuticals (BDRX) to Acquire Exclusive Worldwide License to Tolimidone
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Jean Buteau , Alberta Diabetes Institute , Bukwang Pharmaceutical Co , Biodexa Pharmaceuticals , Company American Depositry , Edison Group Us Investor Relations , Melior Pharmaceuticalsi Inc , National Library Of Medicine , Adhera Therapeutics Inc , Pfizer Inc , University Of Alberta , Adhera Therapeutics , Stephen Stamp , Professor Jean Buteau , Bukwang Pharmaceutical , American Depositry Shares , American Depositary Shares , Bukwang American Depositary , Private Securities Litigation Reform Act ,

Biodexa Pharma Shares Rise On Agreement To Acquire Exclusive Worldwide License To Tolimidone

Biodexa Pharmaceuticals Plc's (BDRX) stock has risen by 157% on Monday following the announcement that it has secured the rights to tolimidone (formerly coded MLR-1023) from Adhera Therapeutics via an exclusive, worldwide, sub-licensable license from Melior Pharmaceuticals. ....

United States , Melior Pharmaceuticals , Company American Depositary , Biodexa Pharmaceuticals Plc , Adhera Therapeutics , American Depositary , American Depositary Shares , Licensing Agreement , Iodexa Pharmaceuticals ,